Thermo Fisher Scientific’s US$11.5bn acquisition of German genetic testing company Qiagen has fallen through after the minimum acceptance threshold condition to the offer was not satisfied. Only 47% of shares…
Thermo Fisher Scientific’s US$11.5bn acquisition of German genetic testing company Qiagen has fallen through after the minimum acceptance threshold condition to the offer was not satisfied. Only 47% of shares…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


